Enteral Branched Chain Amino Acid Formulations

Patients with hepatic encephalopathy have low levels of enteral branched-chain amino acids (BCAAs) and increased levels of phenylalanine and tryptophane. It has been postulated that since BCAAs compete with phenylalanine and trypto-phane for transport through the blood-brain barrier, reduced levels of BCAAs promote the accumulation of these amino acids in the brain, where they are metabolized to false neurotransmitters that then cause encephalopathy. To reverse this state, BCAA-enriched formulas were developed, and in a meta-analysis of randomized controlled trials of these formulations in hepatic encephalopathy, they were shown to reduce the duration of encephalopathy in comatose patients.

Diet And Exercise Expertise

Diet And Exercise Expertise

Get All The Support And Guidance You Need To Be A Success At Dieting And Exercise. This Book Is One Of The Most Valuable Resources In The World When It Comes To Better Physical Personal Development Through Better Living.

Get My Free Ebook


Post a comment